{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:42:33Z","timestamp":1790995353727,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100031918","name":"State Key Laboratory of Natural and Biomimetic Drugs","doi-asserted-by":"publisher","award":["KF2025036"],"award-info":[{"award-number":["KF2025036"]}],"id":[{"id":"10.13039\/100031918","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012632","name":"Nazarbayev University","doi-asserted-by":"publisher","award":["110119FD4531"],"award-info":[{"award-number":["110119FD4531"]}],"id":[{"id":"10.13039\/501100012632","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012632","name":"Nazarbayev University","doi-asserted-by":"publisher","award":["11022021FD2920"],"award-info":[{"award-number":["11022021FD2920"]}],"id":[{"id":"10.13039\/501100012632","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012632","name":"Nazarbayev University","doi-asserted-by":"publisher","award":["040225FD4744"],"award-info":[{"award-number":["040225FD4744"]}],"id":[{"id":"10.13039\/501100012632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.critrevonc.2026.105368","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:07:01Z","timestamp":1778170021000},"page":"105368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Context-dependent rewiring of the cGAS-STING pathway in cancer: Implications for immunotherapy and therapeutic resistance"],"prefix":"10.1016","volume":"224","author":[{"given":"Sidra","family":"Majaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashfaq","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz","family":"Ud-din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikramullah","family":"khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8041-2192","authenticated-orcid":false,"given":"Yingqiu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105368_bib1","doi-asserted-by":"crossref","DOI":"10.1177\/03946320251324821","article-title":"Dissociation between the expression of cGAS\/STING and a senescence-associated signature in colon cancer","volume":"39","author":"Al Shboul","year":"2025","journal-title":"Int. J. Immunopathol. Pharm."},{"key":"10.1016\/j.critrevonc.2026.105368_bib2","article-title":"Mitochondrial DNA release and cGAS-STING activation: emerging insights into anti-tumor immunity","volume":"273","author":"Aloraini","year":"2025","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.critrevonc.2026.105368_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1556736","article-title":"Clinical and molecular implications of cGAS\/STING signaling in checkpoint inhibitor immunotherapy","volume":"12","author":"Chen","year":"2025","journal-title":"Front Mol. Biosci."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105368_bib4","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108599","article-title":"CDK4\/6 inhibitors induce replication stress to cause long-term cell cycle withdrawal","volume":"41","author":"Crozier","year":"2022","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105368_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41573-022-00558-5","article-title":"Targeting replication stress in cancer therapy","volume":"22","author":"da Costa","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105368_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41573-024-01060-w","article-title":"DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications","volume":"24","author":"Drew","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105368_bib7","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.ijrobp.2021.12.162","article-title":"Radiation therapy promotes hepatocellular carcinoma immune cloaking via PD-L1 upregulation induced by cGAS-STING activation","volume":"112","author":"Du","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2026.105368_bib8","article-title":"Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy","volume":"32","author":"Elebiyo","year":"2022","journal-title":"Cancer Treat. Res. Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105368_bib9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1042\/BST20160387","article-title":"Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis","volume":"45","author":"Erdogan","year":"2017","journal-title":"Biochem Soc. Trans."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105368_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/imr.12765","article-title":"STING pathway agonism as a cancer therapeutic","volume":"290","author":"Flood","year":"2019","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105368_bib11","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1021\/acs.chemrev.1c00750","article-title":"Chemical and biomolecular strategies for STING pathway activation in cancer immunotherapy","volume":"122","author":"Garland","year":"2022","journal-title":"Chem. Rev."},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105368_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202500296","article-title":"STING agonists and how to reach their full potential in cancer immunotherapy","volume":"12","author":"Gehrcken","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.critrevonc.2026.105368_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175586","article-title":"The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF","volume":"949","author":"Ghalehbandi","year":"2023","journal-title":"Eur. J. Pharm."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105368_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104412","article-title":"Exploring nucleotide and non-nucleotide cGAS-STING agonists: therapeutic applications and future directions in cancer immunotherapy","volume":"30","author":"Ghara","year":"2025","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105368_bib15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/08923973.2025.2504906","article-title":"Immune checkpoint inhibitors and immunosuppressive tumor microenvironment: current challenges and strategies to overcome resistance","volume":"47","author":"Gill","year":"2025","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105368_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14258","article-title":"The SASP factor IL-6 sustains cell-autonomous senescent cells via a cGAS-STING-NFkappaB intracrine senescent noncanonical pathway","volume":"23","author":"Herbstein","year":"2024","journal-title":"Aging Cell"},{"issue":"18","key":"10.1016\/j.critrevonc.2026.105368_bib17","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res."},{"issue":"7918","key":"10.1016\/j.critrevonc.2026.105368_bib18","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41586-022-04847-2","article-title":"cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers","volume":"607","author":"Hong","year":"2022","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105368_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202400255","article-title":"STING-Activating Small Molecular Therapeutics for Cancer Immunotherapy","volume":"25","author":"Huang","year":"2024","journal-title":"Chembiochem"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105368_bib20","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1186\/s12967-025-06843-2","article-title":"The cGAS-STING pathway: a dual regulator of immune response in cancer and therapeutic implications","volume":"23","author":"Huang","year":"2025","journal-title":"J. Transl. Med."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105368_bib21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12032-024-02539-7","article-title":"Recent advancements in cGAS-STING activation, tumor immune evasion, and therapeutic implications","volume":"41","author":"Islam","year":"2024","journal-title":"Med Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105368_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13045-020-00916-z","article-title":"cGAS-STING, an important pathway in cancer immunotherapy","volume":"13","author":"Jiang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105368_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101276","article-title":"EMT and cancer stem cells: drivers of therapy resistance and promising therapeutic targets","volume":"83","author":"Jiang","year":"2025","journal-title":"Drug Resist Updat"},{"issue":"23","key":"10.1016\/j.critrevonc.2026.105368_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12237442","article-title":"Temozolomide, Procarbazine and Nitrosoureas in the Therapy of Malignant Gliomas: Update of Mechanisms, Drug Resistance and Therapeutic Implications","volume":"12","author":"Kaina","year":"2023","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105368_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25021263","article-title":"Key proteins of replication stress response and cell cycle control as cancer therapy targets","volume":"25","author":"Khamidullina","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105368_bib26","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846935","article-title":"Role of the cGAS-STING pathway in cancer development and oncotherapeutic approaches","volume":"19","author":"Khoo","year":"2018","journal-title":"EMBO Rep."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105368_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ph16121675","article-title":"At the crossroads of the cGAS-cGAMP-STING pathway and the DNA damage response: implications for cancer progression and treatment","volume":"16","author":"Korneenko","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.critrevonc.2026.105368_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1601773","article-title":"Tumor-infiltrating lymphocytes in cancer immunotherapy: from chemotactic recruitment to translational modeling","volume":"16","author":"Kraja","year":"2025","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105368_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4174\/astr.2015.89.1.1","article-title":"Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis","volume":"89","author":"Lee","year":"2015","journal-title":"Ann. Surg. Treat. Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105368_bib30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40164-025-00673-0","article-title":"Homologous recombination-DNA damage response defects increase TMB and neoantigen load, but not effector T cell density and clonal diversity in pancreatic cancer","volume":"14","author":"Lei","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105368_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15164127","article-title":"Conventional DNA-damaging cancer therapies and emerging cGAS-STING activation: a review and perspectives regarding immunotherapeutic potential","volume":"15","author":"Lewicky","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105368_bib32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13045-019-0721-x","article-title":"Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy","volume":"12","author":"Li","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105368_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106939","article-title":"Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment","volume":"88","author":"Li","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105368_bib34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.molcel.2022.12.034","article-title":"Cytosolic DNA sensing by cGAS\/STING promotes TRPV2-mediated Ca(2+) release to protect stressed replication forks","volume":"83","author":"Li","year":"2023","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105368_bib35","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1158\/2326-6066.CIR-23-1078","article-title":"The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS\/STING-Mediated Antitumor Immunity","volume":"12","author":"Lim","year":"2024","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105368_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13045-024-01544-7","article-title":"Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives","volume":"17","author":"Lin","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105368_bib37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.54254\/2753-8818\/2025.21439","article-title":"Research progress of cGAS STING pathway in tumor therapy","volume":"89","author":"Liu","year":"2025","journal-title":"Theor. Nat. Sci."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105368_bib38","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/s41423-021-00655-2","article-title":"Enhancing CAR-T cell efficacy in solid tumors by targeting the tumor microenvironment","volume":"18","author":"Liu","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105368_bib39","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fcell.2019.00060","article-title":"Cancer-associated fibroblasts build and secure the tumor microenvironment","volume":"7","author":"Liu","year":"2019","journal-title":"Front Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105368_bib40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/cas.14266","article-title":"Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer","volume":"111","author":"Loo","year":"2020","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105368_bib41","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163452","article-title":"Understanding and therapeutically exploiting cGAS\/STING signaling in glioblastoma","volume":"134","author":"Low","year":"2024","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.critrevonc.2026.105368_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118023","article-title":"Targeting VEGF signaling for tumor microenvironment remodeling and metastasis inhibition: therapeutic strategies and insights","volume":"186","author":"Mahaki","year":"2025","journal-title":"Biomed. Pharm."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105368_bib43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105368_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.765284","article-title":"Efficient DNA repair mitigates replication stress resulting in less immunogenic cytosolic DNA in radioresistant breast cancer stem cells","volume":"13","author":"Meyer","year":"2022","journal-title":"Front Immunol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105368_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9103323","article-title":"Challenges and opportunities in the clinical development of STING agonists for cancer immunotherapy","volume":"9","author":"Motedayen Aval","year":"2020","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105368_bib46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10388-025-01112-z","article-title":"Activation of the tumor cell-intrinsic STING pathway induced by Fusobacterium nucleatum is associated with poor prognosis in esophageal cancer patients","volume":"22","author":"Nakajima","year":"2025","journal-title":"Esophagus"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105368_bib47","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41423-020-00565-9","article-title":"Tumor-infiltrating lymphocytes in the immunotherapy era","volume":"18","author":"Paijens","year":"2021","journal-title":"Cell Mol. Immunol."},{"issue":"6506","key":"10.1016\/j.critrevonc.2026.105368_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba6098","article-title":"An orally available non-nucleotide STING agonist with antitumor activity","volume":"369","author":"Pan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105368_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115596","article-title":"Strategies involving STING pathway activation for cancer immunotherapy: mechanism and agonists","volume":"213","author":"Pan","year":"2023","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.critrevonc.2026.105368_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.830208","article-title":"Key players of the immunosuppressive tumor microenvironment and emerging therapeutic strategies","volume":"10","author":"Park","year":"2022","journal-title":"Front Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105368_bib51","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.tranon.2019.10.010","article-title":"Homologous recombination repair deficiency and the immune response in breast cancer: a literature review","volume":"13","author":"Pellegrino","year":"2020","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105368_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1133472","article-title":"Targeting the BRCA1\/2 deficient cancer with PARP inhibitors: clinical outcomes and mechanistic insights","volume":"11","author":"Ragupathi","year":"2023","journal-title":"Front Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105368_bib53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.molcel.2020.07.026","article-title":"DNA damage and cancer immunotherapy: a STING in the tale","volume":"80","author":"Reislander","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.critrevonc.2026.105368_bib54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semcancer.2019.07.017","article-title":"Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression","volume":"65","author":"Saleh","year":"2020","journal-title":"Semin Cancer Biol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105368_bib55","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ccell.2025.01.009","article-title":"Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma","volume":"43","author":"Schiantarelli","year":"2025","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105368_bib56","first-page":"733","article-title":"Advances in STING pathway modulation for cancer and immunotherapy: a comprehensive review of preclinical and clinical studies (2020-2024)","volume":"40","author":"Shaik","year":"2025","journal-title":"Cancer Biother Radio."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105368_bib57","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/intimm\/dxaf037","article-title":"TREX1 exonuclease in immunity and disease","volume":"37","author":"Shang","year":"2025","journal-title":"Int Immunol."},{"key":"10.1016\/j.critrevonc.2026.105368_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215919","article-title":"PARPi treatment enhances radiotherapy-induced ferroptosis and antitumor immune responses via the cGAS signaling pathway in colorectal cancer","volume":"550","author":"Shen","year":"2022","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105368_bib59","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13045-025-01691-5","article-title":"The cGAS-STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications","volume":"18","author":"Shen","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105368_bib60","article-title":"DNA damage and activation of cGAS\/STING pathway induce tumor microenvironment remodeling","volume":"9","author":"Shen","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105368_bib61","doi-asserted-by":"crossref","first-page":"8899","DOI":"10.1038\/s41598-023-35092-w","article-title":"Genomic and molecular landscape of homologous recombination deficiency across multiple cancer types","volume":"13","author":"Shi","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105368_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-04845-0","article-title":"Ionizing radiation triggers the release of mitochondrial DNA into the cytosol as a signal of mitochondrial damage","volume":"15","author":"Shimura","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105368_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2020.102894","article-title":"TREX1 - Apex predator of cytosolic DNA metabolism","volume":"94","author":"Simpson","year":"2020","journal-title":"DNA Repair"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105368_bib64","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1158\/2159-8290.CD-23-0700","article-title":"TREX1 inactivation unleashes cancer cell STING-interferon signaling and promotes antitumor immunity","volume":"14","author":"Tani","year":"2024","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105368_bib65","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41401-025-01639-y","article-title":"DNMT inhibition epigenetically restores the cGAS-STING pathway and activates RIG-I\/MDA5-MAVS to enhance antitumor immunity","volume":"47","author":"Tu","year":"2026","journal-title":"Acta Pharm. Sin."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105368_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ph18081082","article-title":"Tumor Microenvironmental dynamics in shaping resistance to therapeutic interventions in melanoma: a narrative review","volume":"18","author":"Turner","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105368_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092249","article-title":"Homologous recombination repair deficiency and implications for tumor immunogenicity","volume":"13","author":"van Wilpe","year":"2021","journal-title":"Cancers"},{"issue":"16_","key":"10.1016\/j.critrevonc.2026.105368_bib68","article-title":"The non-canonical role of homologous recombination deficiency in the development of immune-cold tumor microenvironment","volume":"43","author":"Vasudevan","year":"2025","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105368_bib69","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add8564","article-title":"Synthetic enforcement of STING signaling in cancer cells appropriates the immune microenvironment for checkpoint inhibitor therapy","volume":"9","author":"Vornholz","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.critrevonc.2026.105368_bib70","article-title":"Clinical applications of STING agonists in cancer immunotherapy: current progress and future prospects","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105368_bib71","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12943-025-02380-0","article-title":"Demystifying the cGAS-STING pathway: precision regulation in the tumor immune microenvironment","volume":"24","author":"Wang","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105368_bib72","article-title":"GAS-STING: a classical DNA recognition pathways to tumor therapy","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105368_bib73","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12943-020-01247-w","article-title":"cGAS-STING pathway in cancer biotherapy","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105368_bib74","article-title":"The activation of cGAS-STING pathway offers novel therapeutic opportunities in cancers","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105368_bib75","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12943-024-02179-5","article-title":"Current trends in sensitizing immune checkpoint inhibitors for cancer treatment","volume":"23","author":"Wei","year":"2024","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105368_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061899","article-title":"Cancer-associated fibroblasts: master tumor microenvironment modifiers","volume":"15","author":"Wright","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105368_bib77","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cytogfr.2025.06.002","article-title":"Metabolic regulation of cGAS-STING signaling in the tumor microenvironment: dual immune roles and therapeutic implications","volume":"85","author":"Wu","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105368_bib78","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12943-024-02079-8","article-title":"Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy","volume":"23","author":"Xia","year":"2024","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105368_bib79","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.immuni.2022.06.007","article-title":"Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling","volume":"55","author":"Xian","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2026.105368_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1441222","article-title":"Combined strategies with PARP inhibitors for the treatment of BRCA wide type cancer","volume":"14","author":"Xie","year":"2024","journal-title":"Front Oncol."},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105368_bib81","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1158\/0008-5472.CAN-24-2747","article-title":"Targeting innate immune checkpoint TREX1 is a safe and effective immunotherapeutic strategy in cancer","volume":"85","author":"Xing","year":"2025","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105368_bib82","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s40364-025-00814-x","article-title":"The distinct landscape of tumor immune microenvironment in homologous recombination deficient cancers","volume":"13","author":"Xu","year":"2025","journal-title":"Biomark. Res."},{"key":"10.1016\/j.critrevonc.2026.105368_bib83","article-title":"Immunocytes in the tumor microenvironment: recent updates and interconnections","volume":"16","author":"Yu","year":"2025","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105368_bib84","doi-asserted-by":"crossref","DOI":"10.1042\/EBC20253006","article-title":"The cGAS-STING pathway in cancer immunity: dual roles, therapeutic strategies, and clinical challenges","volume":"69","author":"Yue","year":"2025","journal-title":"Essays Biochem"},{"key":"10.1016\/j.critrevonc.2026.105368_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216182","article-title":"Immune-checkpoint inhibitor resistance in cancer treatment: Current progress and future directions","volume":"562","author":"Zhang","year":"2023","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105368_bib86","first-page":"45","article-title":"Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies","volume":"21","author":"Zhang","year":"2024","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.critrevonc.2026.105368_bib87","first-page":"10","article-title":"Sophisticated roles of tumor microenvironment in resistance to immune checkpoint blockade therapy in hepatocellular carcinoma","author":"Zhang","year":"2025","journal-title":"Cancer Drug Resist 8"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105368_bib88","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ijrobp.2025.04.011","article-title":"Stimulator of interferon genes agonist synergistically amplifies programmed cell death protein-1 blockade and radiation-induced systemic antitumor responses via tumor microenvironment enrichment","volume":"123","author":"Zheng","year":"2025","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2026.105368_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1438364","article-title":"Investigating the impact of STING pathway activation on breast cancer treatment outcomes: development and validation of a prognostic model","volume":"15","author":"Zhong","year":"2024","journal-title":"Front Immunol."},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105368_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713316","article-title":"Significance of the cGAS-STING pathway in health and disease","volume":"24","author":"Zhou","year":"2023","journal-title":"Int. J. Mol. Sci."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826002556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826002556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:59:36Z","timestamp":1783126776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826002556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":90,"alternative-id":["S1040842826002556"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105368","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Context-dependent rewiring of the cGAS-STING pathway in cancer: Implications for immunotherapy and therapeutic resistance","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105368","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105368"}}